1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version

Follow our Twitter feed

View our Linkpartners

General

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) as First-Line Treatment for Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma (48.3KB)
(WorldNews Japan)

16 november 2018 08:51:26

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) as First-Line Treatment for Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma (48.3KB)
(WorldNews Japan)

The text version of this document in not available. You can...

9 viewsCategory: General > Asia > Japan

Another hog cholera infection detected in Gifu
(Japan Today)
NRA Allows Tokai-2 to Be Operated for Sixty Years, a First for a BWR
(WorldNews Japan)

blog comments powered by Disqus

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten